HomeNews
Share

Positive, but not for investors: Anthropic's stock lost momentum after its IPO

The investment bank that helped Anthropic go public fully exercised its right to an additional buyback at the offering price following the stock's rise, thereby depriving the stock of one of its sources of support

Yuliya Kotova

Yuliya Kotova

On the second day of trading on the stock exchange, Anthropics share price approached its IPO price / Photo: Koshiro K / Shutterstock.com

On the second day of trading on the stock exchange, Anthropic's share price approached its IPO price / Photo: Koshiro K / Shutterstock.com

The underwriter for Anthropic’s IPO, which was tasked with stabilizing the stock price after the company’s public offering, has already closed the position set up for that purpose. As a result, the stock—which fell 10% on its second day of trading—has lost one of its potential sources of support, according to Reuters.

The exercise of the option by the underwriters is a positive factor for Anthropic, as it increased the amount of money raised during the IPO, noted Carsten Hesse, head of index events at Berenberg’s London office.

“However, this is less positive for investors, who are losing an important potential source of support for the stock,” he wrote in a client report cited by Reuters. “It appears that the underwriters abandoned the remaining stabilization option just one day after trading began—precisely when the stock price approached the IPO price,” Hesse added.

Details

Anthropic has appointed Morgan Stanley as the stabilization agent for its IPO, according to the company’s prospectus. In this role, the bank has been granted an option to purchase additional shares (known as a “greenshoe”) directly from the company on behalf of the underwriting syndicate.

An over-allotment option gives underwriters the right, within 30 days after the IPO, to purchase additional shares directly from the company at the offering price to cover any oversubscription by investors. An alternative is to buy shares on the open market, which also supports the stock price.

On the first day of trading, Anthropic shares closed at $97.17—about 17% above the IPO price. Anthropic subsequently announced that the underwriters had fully exercised their option, purchasing 147 million shares at the offering price of $83. As a result, the total amount of funds raised during the IPO rose to $93.5 billion. On Friday, shares of the developer of the Claude AI model fell 11.5% to $86.

Full exercise of the greenshoe option means that Morgan Stanley will no longer be able to buy shares on the open market if the stock price falls below the offering price of $83, Reuters reports. One of the agency’s sources noted that market participants questioned the timing of this move—it coincided with increased market volatility on Thursday. Morgan Stanley declined to comment.

Context

Demand for Anthropic shares ahead of the IPO was about seven times greater than supply, Bloomberg reported, citing sources. The company initially set a price range of $70–78 per share, which corresponded to a valuation of up to $1.4 trillion on a fully diluted basis. Given the high demand, the underwriters—Goldman Sachs and Morgan Stanley—expected to close the book at a price above the upper end of that range. Ultimately, judging by the option exercise price, the shares were priced at $83—above the initially announced range.

Anthropic’s successful stock market debut and strong demand during its roadshow have bolstered hopes that other artificial intelligence developers may follow the company’s lead and go public, Reuters reports. Shortly after Anthropic set its IPO price, SB Energy, a developer of data centers and energy infrastructure, updated its prospectus—a move seen as a sign that issuers were preparing to capitalize on investors’ increased appetite. However, these expectations were shaken on the evening of November 19 amid an intensified sell-off of tech stocks.

This article was AI-translated and verified by a human editor

Share

Trending

Stock Screener
Buy
Sell
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Small Caps
Investment and Finance News